Abstract |
Redox regulation of cell cycle progression during nitric oxide (NO) mediated cytostasis is not well-understood. In this study, we investigated the role of the intracellular antioxidant glutathione (GSH) in regulating specific signaling events that are associated with NO-mediated cell cycle arrest. Manipulation of intracellular GSH content through pharmacological inhibition of glutamate-cysteine ligase (GCL) indicated that GSH depletion potentiated nitrosative stress, DNA damage, phosphorylation of the tumor suppressor p53 (Ser-18) and upregulation of p21(cip1/waf1) upon NO stimulation. However, we found that neither overexpression of a dominant negative p53 nor pharmacological inhibition of p53 with cyclic pifithrin-alpha (cPFT-alpha) was sufficient to reverse NO-mediated cell cycle arrest or hypophosphorylation of retinoblastoma protein (Rb). We found that the decrease in cyclin D1 levels induced by NO was GSH-sensitive implying that the redox regulation of NO-mediated cytostasis was a multifaceted process and that both p53/p21(cip1/waf1) and p53 independent cyclin D1 pathways were involved. Together, our results demonstrate that GSH serves as an important component of cellular protective mechanisms against NO-derived nitrosative stress to regulate DNA damage checkpoint.
|
Authors | Qi Lu, Frances L Jourd'Heuil, David Jourd'Heuil |
Journal | Journal of cellular physiology
(J Cell Physiol)
Vol. 212
Issue 3
Pg. 827-39
(Sep 2007)
ISSN: 0021-9541 [Print] United States |
PMID | 17443686
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene
- Benzothiazoles
- Cdkn1a protein, mouse
- Cell Cycle Proteins
- Cyclin D
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
- Enzyme Inhibitors
- Nitric Oxide Donors
- Retinoblastoma Protein
- Triazenes
- Tumor Suppressor Protein p53
- Nitric Oxide
- Toluene
- Buthionine Sulfoximine
- pifithrin
- Glutamate-Cysteine Ligase
- Glutathione
|
Topics |
- Animals
- Benzothiazoles
(pharmacology)
- Buthionine Sulfoximine
(pharmacology)
- Cell Cycle Proteins
(antagonists & inhibitors, genetics, metabolism)
- Cell Proliferation
(drug effects)
- Cyclin D
- Cyclin-Dependent Kinase Inhibitor p21
(metabolism)
- Cyclins
(metabolism)
- DNA Damage
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
(pharmacology)
- Fibroblasts
(drug effects, enzymology, metabolism)
- G1 Phase
(drug effects)
- Glutamate-Cysteine Ligase
(antagonists & inhibitors, metabolism)
- Glutathione
(metabolism)
- Mice
- NIH 3T3 Cells
- Nitric Oxide
(metabolism)
- Nitric Oxide Donors
(pharmacology)
- Oxidation-Reduction
- Phosphorylation
- Retinoblastoma Protein
(metabolism)
- S Phase
(drug effects)
- Toluene
(analogs & derivatives, pharmacology)
- Transfection
- Triazenes
(pharmacology)
- Tumor Suppressor Protein p53
(antagonists & inhibitors, genetics, metabolism)
|